IGF1 and neoplasm: In contrast, myeloid and fibroblastic cells showed differences both between tumor versus WT and G-Smo versus M-Smo tumors, with M-Smo tumors harboring more anti-tumor Cc2+ cells and fewer tumor-promoting Igf1+ cells.